Celldex Therapeutics, Inc. (CLDX) Financials

CLDX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 465.6 million 36.5 million
2023-09-30 280.3 million 33.5 million
2023-06-30 299.3 million 21.8 million
2023-03-31 324.5 million 21.8 million

CLDX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 75.9 million -16.7 million
2023-09-30 -19.2 million 7.1 million
2023-06-30 -27.6 million 5.2 million
2023-03-31 -29.2 million 4.3 million

CLDX Net Income

No data available :(

CLDX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 423.6 million - 2.5 million
2023-09-30 235.3 million - 2.8 million
2023-06-30 252.7 million - 3.3 million
2023-03-31 278.4 million - 3.7 million

CLDX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 48449
2023-09-30 47.3 million
2023-06-30 47.3 million
2023-03-31 47.2 million

CLDX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.2 million 87.3 million 8.8 million -
2023-09-30 157000 34.5 million 8.2 million -
2023-06-30 410000 26.3 million 7.2 million -
2023-03-31 585000 26.8 million 6.6 million -

CLDX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 4.1 million -
2023-09-30 1.5 million 767000
2023-06-30 268000 756000
2023-03-31 967000 726000

CLDX

Price: $42.56

52 week price:
22.11
53.18

Earnings Per Share: -2.86 USD

P/E Ratio: -13.41

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 345800

Ebitda: -30.7 million

Market Capitalization: 2.7 billion

Links: